Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs GameStop Corp. (GME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs GameStop Corp. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while GameStop Corp. trades at $26.66 (market cap $13.73B). The key difference: GameStop Corp. is far larger — about 3.4× Edgewise Therapeutics Inc. Common Stock's market cap, and GameStop Corp. is trading nearer its 52-week high, Edgewise Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and GameStop Corp. for 62 Days on average.
| EWTX | GME | |
|---|---|---|
Market Cap | $4.02B | $13.73B |
Volume | 1,446,128 | 12,710,661 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $27.23 |
52-Week Low | $14.89 | $17.87 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $3.56B | $13.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GME trades at $27.22, down slightly by 0.04% on the day. The stock shows strong technical momentum with bullish moving averages and positive price action near resistance at $28. Fundamentally, the company reported net income of $131.3 million in 2025 with improving profit margins of 25.16%, though revenue declined to $3.82 billion. Recent insider buying by CEO Ryan Cohen and directors has driven positive sentiment, with multiple purchases totaling over $26 million in September 2026.
GME presents a mixed outlook with strong insider confidence but challenging fundamentals. The investment opportunity lies in continued operational turnaround and potential strategic moves, while risks include revenue declines, competitive pressures in retail gaming, and the stock's meme stock volatility. Analyst consensus remains cautious with only 16.7% buy ratings versus 27.8% sells.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →
